Strategies and best practices that guide pharmaceutical market access teams to build strong payer relationships and gain optimal reimbursement.
Improve pharmaceutical product launch sequencing to maximize revenue and ensure global market access.
Optimize market access activities – especially payer relationship priorities – at product launch to obtain maximum reimbursement.
Use comparative effectiveness research to strengthen value stories for payers, patients and physicians.
Benchmark health economics and outcomes research (HEOR) team resources and study metrics to cultivate payer relationships and win reimbursement.
Strategies for attaining formulary position and negotiating prices for U.S. government drug reimbursement requires are growing more sophisticated.
Use patient-reported outcomes to guide product development and improve market access initiatives. Leverage the healthcare consumer perspective to strengthen product value propositions during regulatory approval and reimbursement discussions and to gain insight to drive commercial potential.
In response to payers’ increased pressure on pharmaceutical and medical device prices, the industry is leveraging new research to bolster the value proposition for new drugs and therapies. However, simply developing this information is not enough. Managed markets teams are the effective and efficient solution to convey key data to payers.
Big Data is forcing the pharmaceutical and medical device industries to re-examine every research channel for opportunities to improve various departments’ work. Harness Big Data to increase efficiency of data analysis during prospective and retrospective studies and better meet patient needs through improved market intelligence.
Learn strategies for building an efficient HOL team and discover best practices to get the best results out of payer interactions.
Win reimbursement, improve payer communication and build a world-class managed markets function.